Evidence mapPaperPMID 41301092Full record

ReviewBioengineering (Basel, Switzerland)2025

A Scoping Review of AI-Based Approaches for Detecting Autism Traits Using Voice and Behavioral Data.

Hajarimino Rakotomanana, Ghazal Rouhafzay

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hajarimino RakotomananaDepartment of Computer Science, Université de Moncton, Moncton, NB E1A 3E9, Canada.
Ghazal RouhafzayDepartment of Computer Science, Université de Moncton, Moncton, NB E1A 3E9, Canada.ORCID 0000-0003-3762-0900

Funding

Talent Recruitment Fund of ResearchNB and by PLEIADE of the Université de Moncton NA
6 · The paper itself

Abstract

This scoping review systematically maps the rapidly evolving application of Artificial Intelligence (AI) in Autism Spectrum Disorder (ASD) diagnostics, specifically focusing on computational behavioral phenotyping. Recognizing that observable traits like speech and movement are critical for early, timely intervention, the study synthesizes AI's use across eight key behavioral modalities. These include voice biomarkers, conversational dynamics, linguistic analysis, movement analysis, activity recognition, facial gestures, visual attention, and multimodal approaches. The review analyzed 158 studies published between 2015 and 2025, revealing that modern Machine Learning and Deep Learning techniques demonstrate highly promising diagnostic performance in controlled environments, with reported accuracies of up to 99%. Despite this significant capability, the review identifies critical challenges that impede clinical implementation and generalizability. These persistent limitations include pervasive issues with dataset heterogeneity, gender bias in samples, and small overall sample sizes. By detailing the current landscape of observable data types, computational methodologies, and available datasets, this work establishes a comprehensive overview of AI's current strengths and fundamental weaknesses in ASD diagnosis. The article concludes by providing actionable recommendations aimed at guiding future research toward developing diagnostic solutions that are more inclusive, generalizable, and ultimately applicable in clinical settings.

Indexed as

activity recognitionAutism Spectrum Disorder (ASD)eye gazefacial gesturemachine learningmotor skillsmovement analysismultimodal AIspeech featuresvisual attentionvoice biomarkers

Identifiers

PMID41301092
PMCPMC12649475

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.